The Israeli government finalizes an agreement with Pfizer to purchase 100,000 courses of the anti-viral drug Paxlovid for high-risk patients over the age of 12 years, with delivery expected to begin in one week. (The Times of Israel) COVID-19 pandemic in Israel, COVID-19 drug developmentCOVID-19 pandemic in AsiaCOVID-19 pandemic link embed save